ecancer

Pembrolizumab yielded durable responses in patients with advanced Merkel cell carcinoma

Dr Paul Nghiem - University of Washington, Seattle, USA

28 Apr 2016

SPF30 sunscreens delay melanoma incidence in preclinical model

Dr Christin Burd - Ohio State University, Columbus, USA

26 Apr 2016

T cells expressing two additional receptors (TETARs) for the use in a multiple- hit immunotherapy

Dr Gerold Schuler - Universitätsklinikum, Erlangen, Germany

4 Apr 2016

What does the iManageCancer project hope to achieve?

Prof Gordon McVie - ecancer Managing Editor

23 Dec 2015

Drug resistance mechanisms

Dr Floris Groenendijk - Erasmus Medical Center, Rotterdam, Netherlands

22 Dec 2015

Immunotherapy makes patients’ tumours "melt away"

Dr Joshua Brody - Mount Sinai Medical Center, New York, USA

6 Dec 2015

Cancer Core Europe: where did it come from and what is its future?

Prof Julio Celis - Danish Cancer Society Research Center, Copenhagen, Denmark

4 Dec 2015

Mouse tumour models in the EurocanPlatform project

Prof Anton Berns - Netherlands Cancer Institute (NKI), Amsterdam, The Netherlands

4 Dec 2015

Clinical epidemiology in the EurocanPlatform project

Prof Hermann Bremmer - German Cancer Research Center (DKFZ), Heidelberg, Germany

4 Dec 2015

Therapeutic strategies in the EurocanPlatform project

Prof Josep Tabernero - Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain

4 Dec 2015

Quality assessment, accreditation and metrics in the EurocanPlatform project

Dr Wim van Harten - Netherlands Cancer Institute (NKI), Amsterdam, The Netherlands

4 Dec 2015

Biobanking in the EurocanPlatform project

Dr Peter Riegman - Erasmus University Medical Centre, Rotterdam, The Netherlands

4 Dec 2015

More from ecancer